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Copyright © 200? JCBN Summary Polaprezinc, a chelate compound consisting of zinc and L-carnosine, is clinically
used as a medicine for gastric ulcers. It has been shown that induction of heat shock protein
(HSP) is involved in protective effects of polaprezinc against gastric mucosal injury. In the
present study, we investigated whether polaprezinc and its components could induce HSP70
and prevent acetaminophen (APAP) toxicity in mouse primary cultured hepatocytes.
Hepatocytes were treated with polaprezinc, zinc sulfate or L-carnosine at the concentration of
100 µM for 9 h, and then exposed to 10 mM APAP. Polaprezinc or zinc sulfate increased
cellular HSP70 expression. However, L-carnosine had no influence on it. Pretreatment of the
cells with polaprezinc or zinc sulfate significantly suppressed cell death as well as cellular lipid
peroxidation after APAP treatment. In contrast, pretreatment with polaprezinc did not affect
decrease in intracellular glutathione after APAP. Furthermore, treatment with KNK437, an
HSP inhibitor, attenuated increase in HSP70 expression induced by polaprezinc, and abolished
protective effect of polaprezinc on cell death after APAP. These results suggested that
polaprezinc, in particular its zinc component, induces HSP70 expression in mouse primary
cultured hepatocytes, and inhibits lipid peroxidation after APAP treatment, resulting in
protection against APAP toxicity.
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Introduction
Acetaminophen (APAP) is a harmless analgesic and
antipyretic drug at therapeutic doses. Generally, APAP at
therapeutic doses is metabolized and eliminated as non-toxic
glucuronate and sulfate conjugates [1, 2]. A small portion of
APAP is bioactivated by the cytochrome P450 (CYP) system
to the reactive intermediate N-acetyl-p-benzoquinoneimine
(NAPQI) [3], which is normally detoxified by conjugation
with reduced glutathione (GSH). APAP overdose leads to
severe liver injury in experimental animals and humans
[4,  5]. Excess NAPQI formation causes GSH depletion,
resulting in covalent binding of NAPQI to cellular macro-
molecules [6,  7]. Formation of NAPQI adducts leads to
mitochondria damage, oxidative/nitrosative stresses and lipidT. Nishida et al.
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peroxidation, and ultimately to cell death such as apoptosis
and necrosis [8–11]. Therefore, it has been considered that
increase in NAPQI adducts followed by GSH depletion is
involved in mechanism underlying APAP-induced hepato-
toxicity. In this context, N-acetylcysteine, a cysteine prodrug,
is clinically used as an antidote for APAP overdose.
We have focused on the repair of damaged hepatic proteins
by heat shock protein (HSP) as an additional therapy for
APAP toxicity in the previous studies [12,  13]. HSP is
known to be highly conserved between prokaryotic and
eukaryotic cells, ubiquitously expressed, and induced in
response to various stresses [14]. It plays an important
role in prevention of the incorrect aggregation of proteins
and regulation of protein folding process. HSPs induced
protect organs and cells against a variety of damages and
stresses. In particular, overexpression of HSP70 has been
reported to have potent cytoprotective effects [15–17]. Our
previous study demonstrated that geranylgeranylacetone, an
anti-ulcer drug, protected against APAP-induced liver injury
[13] and LPS-mediated endotoxin shock [18] via induction
of HSP70.
Polaprezinc [N-(3-aminopropionyl)-L-histidinato zinc], a
chelating compound of zinc and L-carnosine, is commonly
used in the treatment of gastric ulcers in Japan [19]. Previous
studies have revealed that polaprezinc prevents gastric
mucosal injury by its antioxidant activity [20, 21], membrane-
stabilizing action [22] and stimulation of mucus production
[23]. In addition, we have shown that polaprezinc suppresses
indomethacin-induced apoptosis via inhibition of caspase-3
activation in rat gastric mucosal cell line, RGM1 [24].
Recently, it has been reported that polaprezinc induces HSP
in gastric and colonic mucosa, and protects against mucosal
damages induced by various stimuli [25–27].
In the present study, we investigated whether polaprezinc
could induce HSP70 in mouse primary cultured hepatocytes
and protect against APAP-induced toxicity.
Materials and Methods
Chemicals
APAP was purchased from Wako Pure Chemical Industries
(Osaka, Japan). Polaprezinc was kindly provided by Zeria
Pharmatheutical Co., Ltd. (Tokyo, Japan). Polaprezinc was
dissolved in 0.4 M (400 mM) HCl. Zinc sulfate and L-
carnosine were purchased from Sigma-Aldrich (St. Louis,
MO) and dissolved in distilled water. KNK437, an inhibitor
of heat shock factor-1, was purchased from Calbiochem
(San Diego, CA) and dissolved in dimethyl sulfoxide.
Rabbit anti-HSP70 polyclonal antibody was purchased
from Medical & Biological Laboratories Co., Ltd. (Nagoya,
Japan). Dulbecco’s modified eagle medium (DMEM) was
obtained from Nissui Pharmaceutical Co., Ltd. (Tokyo,
Japan). Williams E Medium (WEM) was purchased from
Gibco BRL (Grand Island, NY). All other chemicals used
were of analytical grade.
Animals
Male C57BL/6 mice (8–12 weeks old) were purchased
from Japan SLC (Shizuoka, Japan) and housed 5–6 per cage
in plastic cages. The animals were maintained on a 12-h
light/dark cycle under controlled temperature (23 ± 3°C)
and humidity (55 ± 5%) for a week before use in experi-
ments. They were allowed free access to standard laboratory
food and water.
All studies were approved by the Institutional Animal
Care and Use Committee at Tottori University Faculty of
Medicine, and were carried out in accordance with the
National Institutes of Health Guide for Care and Use of
Laboratory Animals.
Isolation and culture of mouse hepatocytes
Hepatocytes were isolated using a modification of the
two-step collagenase perfusion method of Seglen [28]. In
brief, the mice liver was perfused with calcium- and
magnesium-free Hank’s balanced salt solution (HBSS)
containing 0.5 mM EGTA and 10 mM HEPES (pH 7.2) for
5 min and then with HBBS containing 0.05% collagenase D,
0.005% trypsin inhibitor, 10 mM HEPES (pH 7.5) for
20 min. The digested liver was disrupted, filtered through a
150-μm filter and gently shaken in perfusion buffer for
5 min. After isolation, cells were centrifuged (25 × g, 2 min,
three times) in DMEM containing 10% fetal bovine serum
(FBS), 4 mM L-glutamine, 100 units/ml penicillin and 100
μg/ml streptomycin, the medium was replaced to WEM
containing 5% FBS, 4 mM L-glutamine, 10−6 M dexam-
ethason, 10−8 M insulin, 100 units/ml penicillin and 100 μg/
ml streptomycin. The viability of hepatocytes was over 90%
based on trypan blue exclusion test. Hepatocytes in WEM
were plated in 90-mm collagen-coated dishes (1 × 106 cells/
dish) or 96-well plate (1 × 104 cells/well) and incubated at
37°C in a humidified incubator with 5% CO2.
Exposure to reagents
Primary cultured mouse hepatocytes were treated with
polaprezinc, zinc sulfate or L-carnosine at a concentration of
100 μM at 9 h before APAP treatment. APAP (10 mM) was
dissolved in serum free WEM containing 4 mM L-glutamine,
100 units/ml penicillin and 100 µg/ml streptomycin and
added to the culture medium. In some experiments, KNK437
(50 μM) was added at 6 h before polaprezinc treatment.
Analysis of HSP70 contents
HSP70 contents were determined by Western blotting as
described previously [13, 29]. The cells were treated with
polaprezinc, harvested and washed three times with ice-cold
phosphate buffered saline (PBS). Cells were resuspended inPolaprezinc Inhibits Acetaminophen Hepatotoxicity
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lysis buffer containing 10 mM HEPES, 2 mM EDTA, 0.1%
CHAPS, 5 mM dithiothreitol and 1 mM PMSF, left on ice
20 min and immediately centrifuged at 8,500 × g for 15 min
at 4°C. The protein (30 μg) from each sample was separated
by SDS polyacrylamide gel electrophoresis with 12.5%
polyacrylamide gel. The gels were electroblotted onto
polyvinylidene difluoride membranes. The membranes were
incubated with rabbit anti-HSP70 polyclonal antibody
(1:5,000), washed and then incubated with horseradish-
peroxidase-conjugated goat anti-rabbit antibody (Sigma
Chemical Co., St Louis, MO) (1:2,000). The immunoblot
was revealed with an ECLTM Western blotting analysis
system (GE Healthcare Bio-Sciences KK, Tokyo, Japan).
Western blots were quantified with NIH Image.
Zinc concentrations
Hepatic zinc concentrations were determined by atomic
absorption spectrophotometry (Fukuyama Medical Labo-
ratory Co., Ltd., Hiroshima, Japan). After treatment of
hepatocytes with polaprezinc, cells were collected, washed
and lysed for 20 min on ice in lysis buffer (10 mM HEPES
and 0.1% CHAPS). The lysates were centrifuged at
8,500 × g for 15 min at 4°C and the supernatants were used
for zinc measurement.
Cell viability
The viability of hepatocytes was determined using a
commercially available WST-8 assay kit (Seikagaku Bio-
business Co., Tokyo. Japan) according to the manufacture’s
instruction. After attachment of cells to 96-well plate for 6 h,
each well was treated with polaprezinc, zinc sulfate or L-
carnosine and further incubated for 9 h. Thereafter cells in
each well were washed twice with PBS and treated with
APAP. Cell viability was assessed by measurement of the
absorbance at 492 nm in a microplate reader after incubation
of cells in WST-8 solution for 1 h at 37°C.
Lipid peroxidation and glutathione assay
Cells were collected and washed with PBS twice. The
cells were resuspended in PBS and lysed by freezing and
thawing. Then, the cell lysates were homogenated in 0.05 M
phosphate buffer (0.2 M NaH2PO4, 0.2 M Na2HPO4, 0.2 M
Na-EDTA, pH 7.4) under N2 stream. Lipid peroxidation in
mouse primary cultured hepatocytes was measured by a
fuluorometric reaction with thiobarbituric acid as previously
described [13]. Lipid peroxide content was expressed as the
amount of malondialdehyde (MDA) equivalents.
GSH contents in mouse primary cultured hepatocytes
were determined fluorometrically using Thio-Glo1TM as
previous described [30]. Briefly, after attachment of cells
to dishes for 6 h, cells were incubated in the presence or
absence of polaprezinc for 9 h, further incubated in the
presence of APAP in serum free WEM for 3 h. Thereafter
cells were lysed by the same procedure as that in lipid
peroxidation assay. Immediately after addition of 10 mM
ThioGlo-1 to the cell lysates, fluorescence was measured in
a CytoFluor II (Applied Biosystems, Foster city, CA) fluo-
rescence microplate reader using excitation at 360 ± 40 nm
and emission at 530 ± 25 nm.
Protein assay
Protein contents were determined by the method of
Bradford [31], with FBS as a standard.
Statistical evaluations
Data are expressed as means ± standard error (S.E.).
Changes in variables for different assays were analyzed
by Student’s t test or one-way ANOVA. Differences were
considered to be significant at p<0.05.
Results
Expression of HSP70 after polaprezinc, zinc sulfate or L-
carnosine treatment
Induction of HSP70 expression in mouse primary cultured
hepatocytes after polaprezinc treatment was assessed by
Western Blotting analysis. Cells were treated with pola-
prezinc and harvested after 3, 6 or 9 h. The expression of
HSP70 increased in a time-dependent manner and HSP70
content was increased 3.9-fold of control level at 9 h after
polaprezinc (Fig. 1A). We also examined whether zinc sulfate
or  L-carnosine, polaprezinc components, induces HSP70.
Treatment with zinc sulfate increased HSP70 to 6.4-fold of
control level, while L-carnosine treatment did not enhance
HSP70 expression (Fig. 1B).
Intracellular zinc concentrations after polaprezinc or zinc
sulfate treatment
Since zinc reportedly induced HSPs [32, 33], we evaluated
zinc concentrations in mouse hepatocytes after polaprezinc
or zinc sulfate treatment. The intracellular zinc concentra-
tions increased after treatment with each reagent, reached a
peak level after 1 h (1.5- and 1.7-fold of control level,
respectively) and remained unchanged from 1 h onwards
(Fig. 2).
Effect of polaprezinc, zinc sulfate or L-carnosine pretreat-
ment on APAP toxicity
While APAP overdoses cause liver damage in vivo and
in vitro, it has been reported that overexpression of HSP70
protects APAP toxicity [13, 34, 35]. We next investigated
whether polaprezinc, zinc sulfate or L-carnosine improves
cell viability in mouse hepatocytes after APAP treatment
(Fig. 3). The cell viability after APAP decreased in a time-
dependent manner and was 55% of normal level after 12 h.
Treatments of mouse hepatocytes with polaprezinc and zincT. Nishida et al.
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sulfate 9 h before APAP improved cell viability to 89% and
83% of normal level at 12 h, respectively, while L-carnosine
treatment failed to improve the cell viability (62%).
Effect of polaprezinc, zinc sulfate or L-carnosine pretreat-
ment on lipid peroxidation following APAP exposure
We examined the effect of polaprezinc, zinc sulfate or
L-carnosine on lipid peroxidation in mouse hepatocytes
after APAP treatment (Fig. 4). The lipid peroxide content
Fig. 1. Effect of polaprezinc, zinc sulfate or L-carnosine on HSP70 expression. HSP70 expression was analyzed by Western blot as
described in materials and methods. (A) Time course of the expression of HSP70 after polaprezinc treatment. Cells were
incubated in the presence of 100 μM polaprezinc for 0, 3, 6 or 9 h. (B) HSP70 expression 9 h after treatment with polaprezinc,
zinc sulfate or L-carnosine at a concentration of 100 μM. Western blots were quantified with NIH Image. The data are
expressed as means ± SE of 3 separate experiments. PZ; polaprezinc, ZS; zinc sulfate, LC; L-carnosine. **p<0.01 vs initial
(0 h) time point (in A); ##p<0.01 vs control (in B).
Fig. 2. Changes in zinc concentrations after polaprezinc or zinc
sulfate treatment. Cells were incubated in the presence
of polaprezinc or zinc sulfate at a concentration of
100 μM for 0, 1, 3, 6 or 9 h. Zinc concentration was
measured by atomic absorption spectrophotometry. The
data are expressed as means ± S.E. of 5 separate experi-
ments. PZ; polaprezinc, ZS; zinc sulfate. **p<0.01,
*p<0.05 vs initial (0 h) time point of PZ treatment,
##p<0.01 vs initial (0 h) time point of ZS treatment.
Fig. 3. Effect of polaprezinc, zinc sulfate or L-carnosine on cell
viability after APAP exposure. The cell viability was an-
alyzed using WST-8 assay. Cells were treated with pola-
prezinc, zinc sulfate or L-carnosine at a concentration of
100 μM at 9 h before APAP (10 mM) treatment. The
cell viability was measured 0, 6 or 12 h after APAP. The
data are expressed as means ± SE of 7 separate experi-
ments. PZ; polaprezinc, ZS; zinc sulfate, LC; L-carnos-
ine. **p<0.01 vs APAP alone.Polaprezinc Inhibits Acetaminophen Hepatotoxicity
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increased to 2.3-fold of normal level at 12 h after APAP.
Treatment with polaprezinc or zinc sulfate, but not L-
carnosine, at 9 h before APAP significantly reduced the
increased lipid peroxide content to normal level.
Effects of polaprezinc on reduced glutathione contents
following APAP exposure
To determine whether polaprezinc affects GSH contents,
we measured intracellular GSH contents in mouse hepato-
cytes after APAP treatment (Fig. 5). The GSH contents after
APAP decreased to 55% of normal level at 3 h. Treatment
with polaprezinc did not suppressed the decrease in GSH
contents.
KNK437 inhibits HSP70 induction by polaprezinc and
abolishes a protective effect of polaprezinc against APAP
toxiciy
To confirm that increase of HSP70 expression by pola-
prezinc exerts a protective effect against APAP toxicity, we
investigated whether KNK437 inhibits HSP70 expression in
mouse hepatocytes following polaprezinc treatment and
abrogates the protective effect of polaprezinc on APAP
toxicity. Treatment with KNK437 at 6 h before polaprezinc
suppressed the polaprezinc-induced HSP70 expression by
58% (Fig. 6A). Furthermore, the protective effect of pola-
prezinc on the cell viability at 12 h after APAP treatment was
completely suppressed by KNK437 pretreatment (Fig. 6B).
Discussion
The present study demonstrated for the first time that
polaprezinc, in particular its zinc component, induced
HSP70 in mouse primary cultured hepatocytes and protected
against APAP toxicity.
APAP is converted to a highly reactive intermediate
NAPQI by multiple CYPs including CYP2E1, CYP1A2,
CYP3A, CYP2A6 and CYP2D6 [36–39] when it is taken
in a large dose. A growing body of evidence suggests that
CYP2E1 is a primary contributor to APAP biotransforma-
tion among CYPs [40–42]. In our previous study, we found
that  S-allylmercaptocysteine inhibits CYP2E1 activities,
resulting in reduction of NAPQI formation and suppression
of GSH depletion [43]. As mentioned above, NAPQI is
detoxified by GSH conjugation, resulting in a rapid decrease
in hepatocellular GSH to the bottom level about 3 h after
APAP treatment [12, 44]. Zinc, a component of polaprezinc,
is known to increase transcription of γ-glutamylcysteine
synthetase (rate-limiting enzyme of glutathione synthesis)
heavy chain gene via activation of metal-responsive tran-
scription factor 1 [45]. Furthermore, it has been reported
in the study using primary cultured rat hepatocytes that
intracellular zinc content increased to 5-fold of normal level
at 24 h after treatment with 100 μM zinc, and cellular GSH
and metallothionein (MT) levels increased to 2-fold of
normal levels [46]. Therefore, we investigated whether
polaprezinc treatment increases the amount of intracellular
GSH and inhibited APAP-induced GSH consumption. As
shown in Fig. 5, polaprezinc neither affected cellular GSH
Fig. 4. Time course of lipid peroxide content after APAP
exposure. Cells were incubated in the presence of
polaprezinc, zinc sulfate or L-carnosine at a concentra-
tion of 100 μM for 9 h before APAP (10 mM) treatment.
The lipid peroxide content was measured at 0, 3, 6 or
12 h after APAP. The data are expressed as means ± SE
of 3–7 separate experiments. PZ; polaprezinc, ZS; zinc
sulfate, LC; L-carnosine. **p<0.01, *p<0.05 vs APAP
alone at each time point.
Fig. 5. Effect of polaprezinc on intracellular GSH contents after
APAP treatment. Cells were treated with 100 μM
polaprezinc (PZ) 9 h before APAP (10 mM) exposure.
GSH contents were measured at 3 h after APAP. The
data are expressed as means ± SE of 3 separate experi-
ments. **p<0.01, *p<0.05 vs initial (0 h) time point,
respectively.T. Nishida et al.
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content nor inhibited GSH depletion after APAP treatment.
A possible explanation of the discrepancy with the results
for GSH is that treatment of mouse hepatocytes with
100 μM polaprezinc increased cellular zinc content twice
after 9 h in our study, but much more intracellular zinc may
be required to increase GSH. These results indicated that
polaprezinc exhibited its protective effects downstream of
APAP biotransformation by CYP2E1 and detoxication by
GSH conjugation.
In our previous studies, we revealed that HSPs play a
critical role in protection against APAP hepatotoxicity [12,
13]. Moreover the importance of HSPs is strongly supported
by the finding that HSP70 knockout mice are sensitive to
APAP-induced hepatotoxicity [47]. It is considered that
HSP might function downstream of NAPQI formation and
repair the damaged hepatic proteins as so-called “molecular
chaperone” in APAP toxicity. Recently, polaprezinc is
reported to induce HSP70 (HSP72) in rat gastric mucosa,
mouse colonic mucosa, human colon cells, and protect
against injuries induced by a variety of stimuli [25–27, 48].
Therefore, we examined whether polaprezinc could also
prevent APAP toxicity by inducing HSP70. Treatment with
polaprezinc increased HSP70 expression in mouse hepato-
cytes in a time-dependent manner (Fig. 1A), and treatment
with zinc sulfate significantly increased HSP70 in the hepa-
tocytes after 9 h (Fig. 1B). Contrarily, L-carnosine, the other
component of polaprezinc, did not affect HSP70 levels. Zinc
sulfate at low concentrations is shown to induce HSP70 in
HeLa cells and rat hepatocytes [32,  33]. Zinc and other
heavy metals could activate metal responsive element that
is present in the HSP70 promoter region [49]. Therefore, it
is considered that zinc and other heavy metals might induce
HSP synthesis by activation of HSP gene transcription.
Recent reports have shown that HSP70 exhibits anti-
apoptotic function by interacting with components of
apoptotic pathway [50, 51]. As shown in Fig. 6, KNK437,
an inhibitor of HSP synthesis, decreased the induction of
HSP70 in mouse hepatocytes by polaprezinc and abolished
the protective effect of polaprezinc on APAP toxicity. Given
that APAP-induced liver injury is caused by both necrosis
and apoptosis [52], these findings suggest that the protective
effect of polaprezinc might be at least in part due to inhibi-
tion against APAP-induced apoptosis via HSP70 induction.
In the present study, treatments with polaprezinc and zinc
sulfate increased HSP70 expression in mouse hepatocytes
about 3.9-fold and 6.4-fold of control level, respectively.
These data indicate that zinc sulfate may be more effective
in inducing HSP70 and in protecting against APAP hepato-
toxicity than polaprezinc. However, Seiki et al. [53] have
demonstrated that zinc concentration after intragastric admin-
istration of polaprezinc is higher than that of zinc sulfate and
that  L-carnosine enhances the adhesive and/or permeable
action of zinc on gastric mucosa. Zinc concentration in
mouse hepatocytes after treatment with polaprezinc or zinc
sulfate was almost the same (Fig. 2). However, it is known
that  L-carnosine exerts a remarkable enhancing effect on
Fig. 6. Inhibition by KNK437 against HSP70 induction and prevention of APAP toxicity by polaprezinc. Cells were treated with
KNK437 of 50 μM at 6 h before polaprezinc (PZ) treatment. (A) After 6 h, cells were incubated in the presence of 100 μM
polaprezinc for 9 h. HSP70 expression was analyzed by Western blot. (B) After incubation with KNK437 for 6 h followed
by polaprezinc for 9 h, cells were treated with 10 mM APAP. The cell viability was measured at 12 h after APAP. The data are
expressed as means ± SE of 3–7 separate experiments. *p<0.05 vs PZ alone (in A), #p<0.05 vs PZ + APAP (in B).Polaprezinc Inhibits Acetaminophen Hepatotoxicity
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zinc uptake [54]. Therefore, polaprezinc could be a more
promising HSP inducer than only zinc treatment in vivo. We
examined using mouse model whether polaprezinc could be
a promising drug for the HSP-based therapy of APAP insult.
Oral administration of polaprezinc (100 mg/kg) to mice
significantly increased plasma zinc concentration after 1 h
and enhanced hepatic HSP70 induction after APAP (500 mg/
kg, p.o.) administration. Furthermore, treatment with pola-
prezinc at 4 h before APAP administration suppressed the
increase in plasma ALT activity (Nishida, unpublished data).
In addition to HSP-inducing activity, polaprezinc is known
to have an antioxidant activity to inhibit lipid peroxidation
via scavenging superoxide and hydroxyl radicals [20]. It is
well known that oxidative stress plays an important role in
the development of APAP toxicity [11, 55–57]. Recently, it
has been reported that the APAP-induced reactive oxygen
species (ROS) generation followed by lipid peroxidation
in mouse primary hepatocytes induced cell death, and pre-
treatment with melatonin known as a potent antioxidant
suppressed the increase in ROS and lipid peroxides,
resulting in prevention of cell death [58]. In the present
study, polaprezinc or zinc sulfate pretreatment significantly
inhibited lipid peroxidation induced by APAP (Fig. 5), and
improved the decrease in cell viability (Fig. 3). It is likely
that the antioxidant activity of polaprezinc contributes to its
protective effect on APAP toxicity in hepatocytes. However,
it remains to be elucidated whether HSP70 induction by
polaprezinc could be linked to its antioxidant function.
Polaprezinc comprises zinc and L-carnosine as mentioned
above. Zinc has several important biological activities,
including prevention of ROS generation, induction of MT
and inhibition of apoptosis. Zinc treatment has been reported
to protect against hepatic injuries by a variety of hepato-
toxicants such as carbon tetrachloride, ethanol, thioaceta-
mide and APAP [59–62]. MT, an important protein induced
by metals, is shown to play a protective role in a lot of
experimental models [63]. The study using MT-null mice
has demonstrated that zinc pretreatment protects against
APAP-induced hepatotoxicity in wild type mice, but not
MT-null mice [64], indicating that the protective effect of
zinc treatment on APAP toxicity may be related to its MT
induction. Although we examined the expression of MT
after treatment with polaprezinc, unexpectedly it did not
affect cellular MT expression (data not shown). This dis-
crepancy may also be ascribed to the difference in intra-
cellular zinc contents as mentioned above. These findings
suggest that MT induction is not involved in the protective
effect of polaprezinc or zinc sulfate on APAP toxicity in this
model. L-Carnosine is also known as an antioxidant [65]. A
recent study showed that treatment with carnosine inhibited
an increase in lipid peroxidation and prevented hepato-
toxicity in thioacetamide-treated rats [66]. In our experi-
ments, L-carnosine alone neither suppressed APAP-induced
lipid peroxidation nor improved cell viability in mouse
hepatocytes (Figs. 3 and 5).
In conclusion, the present results indicate that pola-
prezinc, an anti-ulcer drug, protects mouse primary cultured
hepatocytes against APAP insult due to HSP70 induction
and inhibition of lipid peroxidation, and suggest that zinc
subcomponent in polaprezinc may play a pivotal role in
cytoprotective actions of the drug.
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